Literature DB >> 27919548

Cognitive decline over time in adults with myotonic dystrophy type 1: A 9-year longitudinal study.

Benjamin Gallais1, Cynthia Gagnon2, Jean Mathieu2, Louis Richer3.   

Abstract

Myotonic dystrophy type 1 (DM1) is an inherited neuromuscular disease with multisystemic involvement including the central nervous system. The evolution of the cognitive profile is a matter of debate, whether an eventual decline could be global or process-specific. Study aims are to describe, compare and document the clinical relevance of the progression of cognitive abilities in DM1 patients with adult and late-onset phenotypes. A total of 115 DM1 patients (90 adult; 25 late-onset) were assessed twice within a 9-year period on cognitive abilities (language, memory, visual attention, processing speed, visuoconstructive abilities and executive functions) and intellectual functioning (WAIS-R 7). A significant worsening over time was observed for verbal memory, visual attention, and processing speed. The progression in cognitive scores correlated with age and disease duration, but not with nCTG, muscular impairment nor education at baseline. Intellectual functioning remained stable. The rate of decline was higher among the late-onset phenotype than in the adult phenotype. Results showed that executive functions, language, and visual memory are impaired earlier in adult life, while verbal memory, visual attention, and processing speed decline later. Globally, results suggest an early and accelerated normal ageing process. This longitudinal study was based on the largest sample and the longest time period studied to date. These findings are highly relevant for clinical practice and genetic counselling.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Attention; Cognitive ageing; Memory; Myotonic dystrophy type 1; Neuromuscular diseases; Neuropsychology

Mesh:

Year:  2016        PMID: 27919548     DOI: 10.1016/j.nmd.2016.10.003

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  23 in total

1.  Longitudinal study in patients with myotonic dystrophy type 1: correlation of brain MRI abnormalities with cognitive performances.

Authors:  T Cabada; J Díaz; M Iridoy; P López; I Jericó; P Lecumberri; B Remirez; R Seijas; M Gomez
Journal:  Neuroradiology       Date:  2020-11-25       Impact factor: 2.804

2.  Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration.

Authors:  Lee-Hsin Wang; Chien-Yu Lin; Yu-Mei Lin; Luc Buée; Nicolas Sergeant; David Blum; Yijuang Chern; Guey-Shin Wang
Journal:  J Neurosci       Date:  2022-05-23       Impact factor: 6.709

3.  Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation.

Authors:  Gayle K Deutsch; Katharine A Hagerman; Jacinda Sampson; Gersham Dent; Jeanne Dekdebrun; Dana M Parker; Charles A Thornton; Chad R Heatwole; Sub H Subramony; Ami K Mankodi; Tetsuo Ashizawa; Jeffrey M Statland; W David Arnold; Richard T Moxley; John W Day
Journal:  Muscle Nerve       Date:  2022-02-28       Impact factor: 3.852

4.  Encoding of facial expressions in individuals with adult-onset myotonic dystrophy type 1.

Authors:  Claire Johnson; Kathleen E Langbehn; Jeffrey D Long; David Moser; Stephen Cross; Laurie Gutmann; Peggy C Nopoulos; Ellen van der Plas
Journal:  J Clin Exp Neuropsychol       Date:  2020-10-07       Impact factor: 2.475

Review 5.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

Review 6.  Of Mice and Men: Advances in the Understanding of Neuromuscular Aspects of Myotonic Dystrophy.

Authors:  Sandra O Braz; Julien Acquaire; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Front Neurol       Date:  2018-07-10       Impact factor: 4.003

7.  Cognitive function and its relationship with brain structure in myotonic dystrophy type 1.

Authors:  Kathleen E Langbehn; Ellen van der Plas; David J Moser; Jeffrey D Long; Laurie Gutmann; Peggy C Nopoulos
Journal:  J Neurosci Res       Date:  2020-02-13       Impact factor: 4.164

8.  Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.

Authors:  Jacob N Miller; Alison Kruger; David J Moser; Laurie Gutmann; Ellen van der Plas; Timothy R Koscik; Sarah A Cumming; Darren G Monckton; Peggy C Nopoulos
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

9.  Neuropsychological and Psychological Functioning Aspects in Myotonic Dystrophy Type 1 Patients in Italy.

Authors:  Edward Callus; Enrico G Bertoldo; Maria Beretta; Sara Boveri; Rosanna Cardani; Barbara Fossati; Elisa Brigonzi; Giovanni Meola
Journal:  Front Neurol       Date:  2018-09-19       Impact factor: 4.003

10.  Outcome Measures for Central Nervous System Evaluation in Myotonic Dystrophy Type 1 May Be Confounded by Deficits in Motor Function or Insight.

Authors:  Mark J Hamilton; John McLean; Sarah Cumming; Bob Ballantyne; Josephine McGhie; Ravi Jampana; Cheryl Longman; Jonathan J Evans; Darren G Monckton; Maria Elena Farrugia
Journal:  Front Neurol       Date:  2018-10-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.